|
July 6, 2011 Dear Advocates, We are pleased to announce the release of this quarter’s issue of Px Wire (Volume 4, Issue 3), AVAC’s quarterly update on HIV prevention research—a one-stop source for information on the full range of HIV prevention research worldwide. Click here to download the current issue. Highlights in this issue include a feature on the new momentum to end the AIDS epidemic in light of the recent HPTN 052 results showing that early ARV treatment is highly protective against transmitting HIV to one’s sexual partner. See the sign-on statement, We CAN End the AIDS Epidemic, for more details and to add your voice. This issue of Px Wire also explores progress in AIDS vaccine research and the need for evolving trial designs to accommodate new trial results such as those from HPTN 052 and iPrEx. You will also find an abbreviated roadmap highlighting sessions on the latest biomedical prevention updates at the upcoming 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention, to take place in Rome this month. For the full HIV prevention roadmap and additional details on how to follow the conference proceedings, click here. As appears each quarter, this issue includes a centerspread with an updated timeline of biomedical HIV prevention efficacy trials and a world map showing where various strategies are being tested. Additional resources including the Px Wire archive, information about subscribing, reprint requests and bulk orders can be found at www.pxwire.org. As always, comments are most welcome at avac@avac.org. Best, |
|||||||||||||||
| |||||||||||||||
